scispace - formally typeset
R

Rita Sahar

Researcher at Israel Institute for Biological Research

Publications -  24
Citations -  872

Rita Sahar is an academic researcher from Israel Institute for Biological Research. The author has contributed to research in topics: Sulfur mustard & Cornea. The author has an hindex of 16, co-authored 24 publications receiving 787 citations.

Papers
More filters
Journal ArticleDOI

Ocular injuries following sulfur mustard exposure--pathological mechanism and potential therapy.

TL;DR: It is suggested that the chronic inflammation and prolonged impairment of corneal innervation are playing a role in the pathogenesis of the delayed LSCD following SM exposure by creating a pathological microenvironment to limbal epithelial stem cells, thus, leading to their slow death and to a second cascade of pathological events eventually resulting in severe long-term injuries.
Journal ArticleDOI

Sarin-induced neuropathology in rats

TL;DR: Sarin has a potent acute and long-term central neurotoxicity, which must be considered in the design of therapeutic regimes, and frontal cortex damage was specific to soman poisoning.
Journal ArticleDOI

Characterization of acute and delayed ocular lesions induced by sulfur mustard in rabbits.

TL;DR: The experimental model for sulfur mustard-induced acute and delayed ocular lesions in rabbits is useful for studying the pathological mechanisms of HD-ocular lesions, and may serve for testing potential therapies.
Journal ArticleDOI

Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits

TL;DR: It is shown that topically applied steroid treatment, administered after HD exposure, attenuated the extent of neovascularization, one of the characteristics of delayed ocular pathology in rabbits.
Journal ArticleDOI

Long-Term Study of Brain Lesions Following Soman, in Comparison to DFP and Metrazol Poisoning

TL;DR: It is suggested that brain lesions are not common for all ChE inhibitors and that convulsions per se are not the only factor leading to brain damage following the administration of soman, and that degenerative process might be due to a secondary effect, unrelated to soman's clinical toxicity, but leading to long-term brain injuries.